Clinical Governance, Safety and Oversight Framework at Jintara

Jintara Rehab is a private, adult-only residential addiction treatment and dual-diagnosis centre operated by Lanna Health Care Company Limited, registered with the Thai Ministry of Public Health as Jintara Wellness Center and Rehab, a drug rehabilitation centre under the Narcotics Act. Registration certificate SFT.50.13-11116 was issued on 8 September 2023. The current Jintara program opened in January 2022.

The registered address is 76 Moo 5, Pa Daet, Mueang Chiang Mai, Chiang Mai, Thailand. Tax ID and legal-entity details are published in the site footer.

Clinical governance claims are straightforward to publish and difficult for a family to verify independently. The hospital-grade accreditation changes that. In May 2026, Jintara Wellness Center and Rehab was assessed against Thailand's national quality standard for drug treatment and rehabilitation facilities and met it, certified jointly by the Healthcare Accreditation Institute, the body that accredits Thailand's hospitals; the Princess Mother National Institute on Drug Abuse Treatment; and the Department of Medical Services, Ministry of Public Health. Certificate no. 25/2569, valid 20 May 2026 to 19 May 2029. Three independent national authorities confirming the same standards documented throughout this page.

Jintara structures psychiatric oversight through addiction-specialist psychiatrists at Bangkok Hospital Chiang Mai and Chiang Mai Ram Hospital rather than holding psychiatrists on staff, keeping oversight independent with no single-physician dependency.

On-site clinical operations are led by Khun Khwan, Head Nurse and Operations Manager, who runs the 24/7 awake nursing rota and co-signs hospital referrals. Jintara holds formal medical care agreements with two partner hospitals in Chiang Mai, dated February 2026 and May 2025 respectively, both compliant with the Thai Personal Data Protection Act (PDPA 2562/2019). The medical-oversight approach follows NIAAA's account of medical detoxification, in which doctors can prescribe medications to address withdrawal symptoms and make the process safer. Some clients see the psychiatrist five, six or seven times across a single program because the plan keeps needing adjustment, and where a review falls on a weekend the team uses clinic pathways so oversight does not pause.

Jintara uses five validated clinical instruments at admission and throughout detox to quantify withdrawal severity and mental-health acuity: CIWA-Ar, COWS, PHQ-9, GAD-7, and 8Q. The CIWA-Ar scale, validated by Sullivan et al. in the British Journal of Addiction, remains the standard measure for alcohol withdrawal monitoring.

Every detox plan at Jintara is written by the admitting psychiatrist on Day 1, informed by substance history, physical examination, and Day 2 hospital workup at Bangkok Hospital Chiang Mai. SAMHSA TIP 45 residential detox protocols guide individual plan adjustments for polysubstance use, co-occurring conditions, and psychiatric risk factors. Therapy starts alongside detox, not after it: the medical detox program brings therapy in from Day 1.

Jintara holds formal hospital care agreements with Bangkok Hospital Chiang Mai (signed February 2026, credit-backed emergency referral) and Chiang Mai Ram Hospital (signed May 2025, two-year term), both governed by the Thai Personal Data Protection Act 2562. SAMHSA TIP 45 identifies documented hospital escalation pathways as a requirement for facilities managing medical withdrawal risk.

When symptoms go beyond what is safe to manage on site, the nursing team follows its emergency protocol and takes the client to a partner hospital straight away, at any hour. The hospital transfer protocol page details each escalation trigger and the process that follows.

Jintara maintains approximately 3.2 staff per client, with 32 staff supporting a maximum of ten clients at any time. SAMHSA TIP 45 guidelines for residential detox recommend around-the-clock awake nursing for facilities managing medical withdrawal. At Jintara, nurses check on each client every one to two hours in early detox, day and night, and less often as withdrawal settles.

Jintara obtains informed consent on admission covering the program structure, medication plan, Thai PDPA data handling, confidentiality limits, and the right to leave except where clinically contraindicated. Consent at Jintara is revisited whenever the treatment plan materially changes.

Confidentiality is governed by the Thai Personal Data Protection Act 2562 (2019). Family contact during treatment is permitted only with the client's written consent, and third-party disclosures (employers, referrers, legal counsel) are routed through the Treatment Manager. Co-occurring medical and psychiatric conditions are documented at admission and managed jointly with the partner-hospital teams. Where a condition falls outside Jintara's operational scope, referral out is preferred to accepting a poor clinical fit.

Transparency about scope is a core part of Jintara's clinical governance. The facility operates within a defined clinical envelope, and admissions will refer when a prospective client's needs fall outside it. NIDA's treatment overview describes several treatment settings, from outpatient counselling to residential programs, so a person can be referred to the setting that fits their needs.